Диссертация (1139787), страница 33
Текст из файла (страница 33)
59-67.170. Чугаев, Ю.П. Инновационные подходы к выявлению и диагностикетуберкулёза у детей/ Ю.П. Чугаев, Т.Е. Тюлькова, Д.Н.Голубев [и др.]//Фтизиатрия и пульмонология. – 2014. - № 1(8). – С. 119-126.171. Яблонский, П.К. Диаскинтест в практической работе общей лечебной сети миф или реальность? / П.К. Яблонский, И.Ф.Довгалюк, С.В. Зубарева,Н.В.Корнеева, А.А. Старшинова // Практическая медицина. – 2012. -Т.56, № 1. –С. 65-69.современных172.Яблонский,П.К.Значениедиагностикетуберкулёзаудетей/иммунологическихП.К.Яблонский,тестоввИ.Ф.Довгалюк,А.А.Старшинова, О.А.Якунина // Медицинская иммунология. – 2013. -Т.15, № 1.– С. 37-34.173.
Яблонский, П.К. Российская фтизиатрия сегодня- выбор пути развития / П.К.Яблонский // Медицинский альянс. – 2013. - № 3. – С. 5-24.174.Ягудина, Р.И. Фармакоэкономическое исследование лекарственных средствдля диагностики туберкулёзной инфекциии/Р.И. Ягудина, И.Ю. Зинчук //ФАРМАКОЭКОНОМИКА.Современнаяфармакоэкономикаифармакоэпидемиология. - 2013.-том 6.-№1.- С. 11-15.175.Янченко, Е.Н.
Туберкулез у детей и подростков / Е.Н. Янченко, М.С. Греймер// Кн. СПб.- 1999. - С.15-19.176.Яровая, Ю.А. Выявление и выраженность туберкулеза у школьников 7-12 лет/Ю.А. Яровая [и др.] // Туберкулез и болезни легких. - 2013. - № 6. - С.103-104.177.Ahmad, S. Pathogenesis, immunology, and diagnosis of latent Mycobacteriumtuberculosis infection/ Ahmad, S. // Clinical and Developmental Immunology. - 2010.P. 1-17.222178.Aiken, A. Reversion of the ELISPOT test after treatment in Gambian tuberculosiscases /Aiken A., Hill P., Fox A.[ et al. ] // BMC Infect Dis. - 2006. - Vol.6.
- P. 66.179.American Thoracic Society, CDC, and Infectious Diseases Society of America.Treatment of tuberculosis, MMWR 2003;52(No. RR-11):1--74. 122180.Andersen, P. Recall of long-lived immunity to Mycobacterium tuberculosisinfection in mice]/ P. Andersen, A. Andersen, Sorensen, S. Nagai //J. Immunol.
- 1995.- Vol. 154.- N. 7 - P. 3359 - 3372.181. Andersen, P. Specific immune-based diagnosis of tuberculosis / P. Andersen, M.E.Munk, J.M. Pollock, T.M. Doherty //Lancet 2000;356:1099—1104182.Andersen, P. The prognosis of latent tuberculosis: can disease be predicted / P.Andersen, T.
Doherty, M. Pai, K. Weldingh //Trends Mol. Med. - 2007 - Vol. 13. -N.5.P. 175183.Arend, S. Detection of active tuberculosis infection by T cell responses to earlysecreted antigenic target 6- KДa protein and culture filtrate protein 10/ Arend S.,Andersen P., van Meijgaarden K. [et al.] // J. Infect. Dis. - 2000.
- Vol. 181. - P.18501854184.Arend, S. Comparison of two interferon-gamma assays and tuberculin skin test fortracing tuberculosis contacts / S. Arend, E. Leyten [ et al.] //Am. J. Respir. Crit. CareMed. - 2007. - Vol. 175. -N.6.- P. 618-627185.BakirM. Prognostic value of a T-cell-based, interferon-gamma biomarkerinchildren with tuberculosis contact / M Bakir, K Millington, A Soysal[ et al.] //Ann.Intern. Med. - 2008.
- Vol. 149. -N.11.-P. 777-787186.Behr, M.Comparative genomics of BCG vaccines by whole-genome DNAmicroarray/Behr M., Wilson M., Gill W. [et al.] // Science. - 1999. - V. 284. - P. 15201523.187.Belknap, R. Diagnosis of Latent Tuberculosis Infection in U.S. Health CareWorkers: Reproducibility, Repeatability and 6 month Follow-up with Interferon gammarelease assays (IGRAs)/Belknap R., Kelahar J., Wall K., [et al.] //Am J Respir Crit CareMed. 2009.Vol.179.-P.A4101.223188.Brock, I. Performance of whole blood IFN-gamma test for tuberculosis diagnosisbased on PPD or the specific antigens ESAT-6 and CFP-10 /Brock I., Münk M., KokJensen A.[et al.]// Int. J. Tuberc.
Lung Dis. - 2001. - Vol.5. - P.462-467.189.Brock, I. Latent tuberculosis in HIV positive, diagnosed by the M. tuberculosisspecific interferon-gamma test /Brock I., Ruhwald M., Lundgren B. [et al // Respir Res.- 2006. - Vol.7. - P. 56.190.Brock, I. Comparison of tuberculin skin test and new specific blood test intuberculosis contacts /Brock I., Weldingh K., Lillebaek T.
[et al.]// Am J RespirCritCare Med. - 2004. - Vol. 170. - P.65-69.191.Brock, I. Comparison of tuberculin skin test and new specific blood test intuberculosis contacts/Brock I., Weldingh K., Lillebaek T. [et al.]// Am J RespirCritCare Med. - 2004. - Vol. 170. - P.65-69.192.CDC. Guidelines for preventing the transmission of Mycobacterium tuberculosis inhealth-care settings, 2005.
MMWR 2005;54(in press).193.CDC. Guidelines for the investigation of contacts of persons with infectioustuberculosis: recommendations from the National Tuberculosis Controllers Associationand CDC. MMWR 2005;54(No. RR-17):1--47.194.CDC. Guidelines for using the QuantiFERON®-TB test for diagnosing latentMycobacterium tuberculosis infection. MMWR 2003;52 (No. RR-2):15--8.195.CDC. Targeted tuberculin testing and treatment of latent tuberculosis infection.MMWR 2000;49(No. RR-6):1--54.
123196.Clinical manifestation and outcome of tuberculosis in children with acquiredimmunodeficiency syndrome / S.P. Chan [ et al.] // Pediatr. Infect. Dis. J. – 1996. -Vol.15, № 5. – P. 443-447.197.Clinical presentation and outcome of tuberculosis in human immunodeficiencyvirus infected children on antiretroviral therapy / E. Walters [et al.] // BMC Pediatrics. –2008. – Vol. 8. – P. 1.198.Clinical presentation of tuberculosis in culture-positive children. PediatricTuberculosis Consortium / M. Burroughs[ et al.] // Pediatr.
Infect. Dis. J. – 1999. – Vol.18, № 5. – P. 440–446. 334224еп199.Clinical features and outcome in children admitted to a TB hospital in theWestern Cape-the influence of HIV infection and drug resistance / M. Soeters [et al.] //South African Med. J. – 2005. – Vol. 95, № 8. – P. 602-606.200.Coker, R.J. Tuberculosis control in Samara Oblast, Russia: institutional andregulatory environment / Coker R.J., Dimitrova B., Drobniewski F.[et al.] // Int JTuberc. Lung Dis.
- 2003. - Vol. 7(10). - P. 920-32.201.Cole, S.Deciphering the biology of Mycobacterium tuberculosis from thecomplete genome sequence /Cole S., Brosch R., Parkhill J. [et al.] // Nature. - 1998. Vol. 393. - P. 537-544.202.Comstock, G.V. A comparison in the United States of America of two tuberculins,PPD-S and RT 23 / Comstock G.V., Edwards L.B., Philip R.N., Winn W.A. // BullWorld Health Organ 1964;31:161--70.203.Community-based therapy for multidrug- resistant tuberculosis in Lima, Peru / C.Mitnick [et al.] // N. Engl.
J. Med. - 2003. – Vol. 348. – P. 119-128.204.Comparison of a whole-blood interferon gamma assay with tuberculin skin testingfor detecting latent Mycobacterium tuberculosis infection / G.H. Mazurek [et al.] // J.Am. Med. Assoc. – 2001. – Vol. 286, № 14. – P. 1740-1747.205.Connell, Т. Performance of a whole blood interferon gamma assay for detectinglatent infection with Mycobacterium tuberculosis in children / Connell Т., Curtis N.,Ranganathan S., Buttery //Thorax.-2006. - Vol.
61. - P. 616-620.206.Connell ,T. A three-way comparison of tuberculin skin testing, QuantiFERON TBGold and T-SPOT.TB in children/ Connell T., Ritz N., Paxton G.[ et al.] // PLoS. ONE 2008. - Vol. 3.-e2624. doi:10.1371/journal.pone.0002624207.Covert, B. The application of proteomics in defining the T-cell antigens ofMycobacterium tuberculosis /Covert B., Spencer J., Orme I., Belisle J. II Proteomics.2001.-Vol. l.-P.
574-586.208.Culture positive tuberculosis in human immunodeficiency virus type 1-infectedchildren / H.S. Schaaf [et al.] // Pediatr. Infect. Dis. J. - 1998. – Vol. 17, №7. – P. 599604.225209.Desem, N. Development of a human interferon - y enzyme immunoassay andcomparison with tuberculin skin testing for detection of Mycobacterium tuberculosisinfection / Desem, N., Jones, S.L. // Clin. Diag. Lab. Immunol. 1998. - №5. - Р.5316.210.Detjen, A. Short-term Reproducibility of a Commercial Interferon-gamma ReleaseAssay/ Detjen A., Loebenberg L., Grewal H., [et al.] // Clin Vaccine Immunol.
2009;16(8): 1170-1175.211.Diagnosis of tuberculosis in South African children with a T-cell based assay: aprospective cohort study / S. Liebeschuetz [et al.] // Lancet. – 2004. - Vol. 364(9452). –P. 2196-2203. 336212.Diet, R. Predictive value of a whole blood IFN-gamma assay for the developmentof active tuberculosis disease after recent infection with Mycobacterium tuberculosis/Diet R., Loddenkemper R., Meywald-Walter K. [et al.]//Am. J. Respir. Crit. Care Med.- 2008. - Vol.
177.-N. 10.-P. 1164-1170.213.Dietrich, J. Exchanging ESAT6 with ТВ 10.4 in an Ag85B fusion moleculebasedtuberculosis subunit vaccine: efficient protection and ESAT6-based sensitivemonitoring of vaccine efficacy / Dietrich J., Aagaard C, Leah R.[ et al.]//J. Immunol. 2005. - Vol. 174. - P. 6332-6339.214.Dillon, D. Molecular and immunological characterization of Mycobacteriumtuberculosis CFP-10, an immunodiagnos- tic antigen missing in Mycobacterium bovisBCG /Dillon D., Alderson M., Day H. [et al.] // J.
Clin. Microbiol. - 2000. - Vol. 38. P.3285-3290.215.Doherty, T. Immune responses to the Mycobacterium tuberculosis-specific antigenESAT-6 signal subclinical infection among contacts of tuberculosis patients /DohertyT., Demissie A., Olobo J. [et al.] // J Clin Microbiol. - 2002. - Vol. 40(2). - P. 704-706.216.Dosanjh, D.
Improved diagnostic evaluation of suspected tuberculosis /Dosanjh D.,Hinks T., Innes J., [et al.] // Ann Intern Med. - 2008. - Vol. 148. - P. 325-336.217.Ewer, K. Dynamic antigen-specific T- cell responses after point-source exposure toMycobacterium tuberculosis/Ewer K., Millington K., Deeks J.[ et al.]II Am J RespirCrit Care Med. - 2006. - Vol. 174. - P. 831 -839.218.Global tuberculosis report 2013 .
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
